Loading...
Please wait, while we are loading the content...
Similar Documents
Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Huang, Haili Hu, Min Zhao, Rui Li, Peng Li, Mingyi |
| Copyright Year | 2013 |
| Abstract | The aim of the present study was to evaluate the antitumor mechanism of dihydromyricetin (DHM). Results showed that DHM significantly inhibited cell viability of HepG2 and Hep3B cells in a dose-dependent manner. DHM induced G2/M cell-cycle arrest in HepG2 and Hep3B cells by altering the expression of cell cycle proteins such as cyclin A, cyclin B1, Cdk1, p53, Cdc25c, p-Cdc25c Chk1 and Chk, which are critical for G2/M transition. Knockdown of p53 and Chk1 in HepG2 cells did not affect G2/M phase arrest caused by DHM. Furthermore, G2/M arrest induced by DHM can be disrupted by Chk2 siRNA. These findings indicate that DHM inhibits the growth of hepatocellular carcinoma (HCC) cells via G2/M phase cell cycle arrest through Chk1/Chk2/Cdc25C pathway. The present study identified effects of DHM in G2/M phase arrest in HCC and described detailed mechanisms of G2/M phase arrest by this agent, which may contribute to its overall cancer preventive efficacy in HCC. |
| Starting Page | 228 |
| Ending Page | 232 |
| Page Count | 5 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.spandidos-publications.com/or/30/5/2467/download |
| PubMed reference number | 24002546v1 |
| Alternate Webpage(s) | https://doi.org/10.3892/or.2013.2705 |
| DOI | 10.3892/or.2013.2705 |
| Journal | Oncology reports |
| Volume Number | 30 |
| Issue Number | 5 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Cardiac Arrest Cell Cycle Arrest Cell Survival Cyclin A Cyclin B1 Liver carcinoma Negative Regulation of Mitosis Neoplasms dihydromyricetin |
| Content Type | Text |
| Resource Type | Article |